Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Bristol Myers reveals a pair of Phase 3 wins for fibrosis, RayzeBio drugs

Bristol Myers Squibb reported two Phase 3 successes on Monday morning, including for an experimental drug that recently ran into safety issues. A trial testing the lung disease program admilparant succeeded ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Monday 12 October →